A provider comparison becomes more useful when each claim is matched with the source that could support it. This shortlist identifies three offers to examine while asking separate questions about price, clinical process, and medical evidence.
CoreAge Rx holds the first position as our featured commercial partner. The ordering is sponsored, not a ranking of research quality or treatment outcomes. No score here establishes that a provider's medicine is clinically superior.
A provider comparison becomes more useful when each claim is matched with the source that could support it. This shortlist identifies three offers to.
Our reading method
Official pages were checked on September 22, 2026. Provider statements document the advertised service, while medical conclusions require relevant clinical evidence. The NIH study-design explanation and FDA compounding overview help keep those questions separate.
1. CoreAge Rx
From $99/month. Advertised starting rate; confirm prepayment, supply, and renewal.
Its marketing discusses sleep, recovery, muscle, and body composition. We have not verified those outcomes in CoreAge Rx patients. A schedule of expected improvements on a sales page is not a personal prediction, and the decision to continue treatment should depend on the clinician's assessment of benefit, burden, and risk. Ask: Does the $99 starting offer apply to my prescription, and what exact amount is charged now and at renewal? Read the CoreAge Rx review and official offer with additional provider details.
2. SuperHealthy Rx
From $195 for a one-month supply. SuperHealthy’s anti-aging page identifies sermorelin and displays a $195 starting price for a one-month supply. It describes an online assessment, physician review and pharmacy delivery. The supply period and the actual invoice should remain beside that starting figure.
The page promotes changes in sleep, recovery and body composition. We have not independently verified those outcomes for this service or its dispensed preparation. Claims that a treatment removes the risks of another hormone product should not substitute for an individual discussion of risks and alternatives.
Read the SuperHealthy Rx review or current official details.
3. Hone Health
$175/month without membership. Async-care help page lists $130/month for members, with membership charged separately. Confirm the selected care model and state availability.
A large biomarker panel, program-wide testimonials, and a proposed hormonal mechanism do not establish an individual sermorelin outcome. Ask: Am I choosing standalone async care or a membership, and what clinical contact, tests, and charges does that choice include? Read the Hone Health review and official offer with additional provider details.
4. AlphaMD
$229.99 for a stated 10–15 week supply. California price is $264.99. Supply depends on the clinician's recommendation. The shop displays an active-TRT restriction for ancillary medications; confirm sermorelin access and additional costs.
The shop title mentions other peptide names; that wording is not an ingredient list or evidence that treatments are interchangeable. Obtain the exact proposed preparation from the clinician and pharmacy. Ask: Is sermorelin available to me without an active TRT subscription, and what exact preparation, supply period, and total charges would apply? Read the AlphaMD review and official offer with additional provider details.
5. Pallas Health
$139 introductory month. Then $597 every 12 weeks under the displayed offer. Other plans have separate terms. The product FAQ limits this program to adults age 55 and under; prescribing and state availability require confirmation.
Pallas cites small historical studies, including work with a related GHRH analog. Those references do not establish outcomes for its current compounded prescription or for every eligible applicant. Read the Pallas Health review and provider page with additional terms.
Availability watch: Promise — visits paused
Visits paused; waitlist only. Live page checked September 23, 2026 says a prescriber-network transition has paused visits. No current purchasable price or reopening date was verified. Search-indexed prices are not treated as active offers.
An educational product page and historical terms cannot establish current prescribing access, fulfillment capacity, or the future pharmacy assignment during a network transition. Read the Promise review and provider page with additional terms.
Ask for the source behind the benefit
If a claim matters to your decision, request the reference and read what was actually studied. Identify the treatment, patient population, comparison, outcome, and limitations. A mechanism description or a testimonial should not quietly take the place of a relevant clinical result.
The study-design guide explains how to approach different kinds of evidence. The trial-registration guide addresses a common confusion: a planned study and a completed result are different documents.
Preserve the conditions attached to an offer
A starting price, member medication discount, or multiweek supply estimate is meaningful only with its qualifications. Ask for the actual proposed preparation, selected care arrangement, and complete charges. If an eligibility condition remains unclear, leave the comparison unresolved until the provider answers it.
The CoreAge Rx versus Hone comparison uses this approach. AlphaMD's shop notice and title wording deserve the same care when deciding what the public information establishes.
Avoid making the review more certain than its sources
We did not purchase medication, audit pharmacies, attend appointments, or measure patient outcomes. A detailed article does not remove those limitations. Our methodology explains the scope of editorial research and the disclosed commercial relationship.
A useful evidence conversation may clarify an appropriate treatment, identify further investigation, or show that a claim is not relevant to your situation. The purpose of this shortlist is to help you ask that conversation's next question, not to promise its answer.
Continue with the latest focused shortlist for a different set of comparison questions.
Availability check: Remedy Meds
Sermorelin offering not verified. General telehealth and compounding information cannot establish a specific treatment offering. This record distinguishes an unverified public offer from an explicit service pause or a proven permanent absence. Read the Remedy Meds availability review and official website. This entry is outside the active-provider ranking.
The source notes
Sources & further reading
Provider pages document advertised offers, not independently proven outcomes. Historical references may concern different products or uses. Check the dated discussion in each article for the scope of our research; offers can change.